Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 11

1.

Automated patient-specific transperineal ultrasound probe setups for prostate cancer patients undergoing radiotherapy.

Camps SM, Verhaegen F, Vanneste BGL, de With PHN, Fontanarosa D.

Med Phys. 2018 Jul;45(7):3185-3195. doi: 10.1002/mp.12972. Epub 2018 Jun 14.

PMID:
29757474
2.

The Use of Ultrasound Imaging in the External Beam Radiotherapy Workflow of Prostate Cancer Patients.

Camps SM, Fontanarosa D, de With PHN, Verhaegen F, Vanneste BGL.

Biomed Res Int. 2018 Jan 24;2018:7569590. doi: 10.1155/2018/7569590. eCollection 2018. Review.

3.

Simulation of pseudo-CT images based on deformable image registration of ultrasound images: A proof of concept for transabdominal ultrasound imaging of the prostate during radiotherapy.

van der Meer S, Camps SM, van Elmpt WJ, Podesta M, Sanches PG, Vanneste BG, Fontanarosa D, Verhaegen F.

Med Phys. 2016 Apr;43(4):1913. doi: 10.1118/1.4944064.

PMID:
27036587
4.

Genotype-phenotype complexity of the TR46/Y121F/T289A cyp51A azole resistance mechanism in Aspergillus fumigatus.

Snelders E, Camps SM, Karawajczyk A, Rijs AJ, Zoll J, Verweij PE, Melchers WJ.

Fungal Genet Biol. 2015 Sep;82:129-35. doi: 10.1016/j.fgb.2015.06.001. Epub 2015 Jun 16.

PMID:
26092193
5.

Aspergillosis due to voriconazole highly resistant Aspergillus fumigatus and recovery of genetically related resistant isolates from domiciles.

van der Linden JW, Camps SM, Kampinga GA, Arends JP, Debets-Ossenkopp YJ, Haas PJ, Rijnders BJ, Kuijper EJ, van Tiel FH, Varga J, Karawajczyk A, Zoll J, Melchers WJ, Verweij PE.

Clin Infect Dis. 2013 Aug;57(4):513-20. doi: 10.1093/cid/cit320. Epub 2013 May 10.

PMID:
23667263
6.

Discovery of a HapE mutation that causes azole resistance in Aspergillus fumigatus through whole genome sequencing and sexual crossing.

Camps SM, Dutilh BE, Arendrup MC, Rijs AJ, Snelders E, Huynen MA, Verweij PE, Melchers WJ.

PLoS One. 2012;7(11):e50034. doi: 10.1371/journal.pone.0050034. Epub 2012 Nov 30.

7.

Molecular epidemiology of Aspergillus fumigatus isolates harboring the TR34/L98H azole resistance mechanism.

Camps SM, Rijs AJ, Klaassen CH, Meis JF, O'Gorman CM, Dyer PS, Melchers WJ, Verweij PE.

J Clin Microbiol. 2012 Aug;50(8):2674-80. doi: 10.1128/JCM.00335-12. Epub 2012 Jun 6.

8.

Triazole fungicides can induce cross-resistance to medical triazoles in Aspergillus fumigatus.

Snelders E, Camps SM, Karawajczyk A, Schaftenaar G, Kema GH, van der Lee HA, Klaassen CH, Melchers WJ, Verweij PE.

PLoS One. 2012;7(3):e31801. doi: 10.1371/journal.pone.0031801. Epub 2012 Mar 1.

9.

Rapid induction of multiple resistance mechanisms in Aspergillus fumigatus during azole therapy: a case study and review of the literature.

Camps SM, van der Linden JW, Li Y, Kuijper EJ, van Dissel JT, Verweij PE, Melchers WJ.

Antimicrob Agents Chemother. 2012 Jan;56(1):10-6. doi: 10.1128/AAC.05088-11. Epub 2011 Oct 17. Review.

10.

Comment on: Low prevalence of resistance to azoles in Aspergillus fumigatus in a French cohort of patients treated for haematological malignancies.

Verweij PE, Camps SM, Kema GH, Melchers WJ.

J Antimicrob Chemother. 2011 Apr;66(4):954-5; author reply 955. doi: 10.1093/jac/dkr008. Epub 2011 Jan 31. No abstract available.

PMID:
21393215
11.

How to use clinical vignettes in hematology--a pilot survey in the context of chronic lymphocytic leukemia.

Camps SM, Chevret S, Lévy V.

Leuk Res. 2009 Oct;33(10):1328-34. doi: 10.1016/j.leukres.2008.11.008. Epub 2008 Dec 17.

PMID:
19095303

Supplemental Content

Loading ...
Support Center